Presentation by Leader of Innovative Scripps Genomic Medicine Program to
Include Data on Novel Genomic Markers for Cardiac Disease
SAN DIEGO, March 26 /PRNewswire/ -- Eric J. Topol, M.D., chief academic officer of Scripps Health and director of the Scripps Translational Science Institute, will present a late-breaking lecture about advancements in the genomics of cardiovascular disease at the American College of Cardiology's (ACC) 57th Annual Scientific Session in Chicago.
Dr. Topol's presentation on March 31 will include data concerning new,
compelling genomic markers for myocardial infarction, coronary artery
disease, atrial fibrillation and abnormal lipoproteins. A panel discussion
about the progress, limitations, caveats and future issues in
cardiovascular genomic medicine will follow the presentation.
Who: Eric J. Topol, M.D., Chief Academic Officer, Scripps Health;
Director of Scripps Translational Science Institute; Professor of
Translational Genomics, The Scripps Research Institute
What: Late-breaking lecture about advancements in the genomics of
When: 3:30 p.m.-4:30 p.m. CDT, March 31
Where: North Hall B1, McCormick Place, Chicago
About Scripps Genomic Medicine
An initiative of Scripps Health and The Scripps Research Institute,
Scripps Genomic Medicine is an innovative program in which genomic
researchers, clinicians and other specialists are working side-by-side to
advance medicine. Current projects include the genotyping of tens of
thousands of individuals of diverse ancestry to identify and define genes
that are responsible for major disease and the underpinnings of health.
Through The Scripps Translational Science Institute, this basic research
will be translated into drug discovery programs and, ultimately, clinical
trials. These trials, launched through Scripps Advanced Clinical Trials,
|SOURCE Scripps Health|
Copyright©2008 PR Newswire.
All rights reserved